{"entity":{"type":"insider","cik":"0001643071","url":"/insider/0001643071","json_url":"/insider/0001643071.json","name":"Pande Atul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":32,"first":"2019-06-17","last":"2026-07-24","span_basis":"filed_date"},"name_variants":[{"name":"Pande Atul","source":"filing","n_filings":32,"first_seen":"2019-06-17","last_seen":"2026-07-24"}],"transactions":[{"id":6220408,"accession":"0001643071-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001643071-26-000007","line_url":"/filing/0001643071-26-000007#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":39.8,"price_display":"39.80","price_state":"stated","total_value":59700.0,"total_display":"59,700.00","total_whole":"59,700","shares_owned_after":116731.0,"shares_owned_after_display":"116,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-24","scope":"insider"},{"id":6175796,"accession":"0001764013-26-000071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-26-000071","line_url":"/filing/0001764013-26-000071#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":38.01,"price_display":"38.01","price_state":"stated","total_value":57015.0,"total_display":"57,015.00","total_whole":"57,015","shares_owned_after":116731.0,"shares_owned_after_display":"116,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-26","scope":"insider"},{"id":5758437,"accession":"0001764013-26-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001764013-26-000069","line_url":"/filing/0001764013-26-000069#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":34.02,"price_display":"34.02","price_state":"stated","total_value":51030.0,"total_display":"51,030.00","total_whole":"51,030","shares_owned_after":116731.0,"shares_owned_after_display":"116,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":5934090,"accession":"0001643071-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001643071-26-000004","line_url":"/filing/0001643071-26-000004#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":32.0,"price_display":"32.00","price_state":"stated","total_value":192000.0,"total_display":"192,000.00","total_whole":"192,000","shares_owned_after":116731.0,"shares_owned_after_display":"116,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-20","filed_date":"2026-05-20","scope":"insider"},{"id":3101295,"accession":"0001764013-24-000200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-24-000200","line_url":"/filing/0001764013-24-000200#line-1","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7750.0,"shares_display":"7,750","price_per_share":28.54,"price_display":"28.54","price_state":"stated","total_value":221185.0,"total_display":"221,185.00","total_whole":"221,185","shares_owned_after":86663.0,"shares_owned_after_display":"86,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":8181920,"accession":"0001764013-23-000155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001764013-23-000155","line_url":"/filing/0001764013-23-000155","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12350.0,"shares_display":"12,350","price_per_share":39.730161943319835,"price_display":"39.73","price_state":"stated","total_value":490667.5,"total_display":"490,667.50","total_whole":"490,668","shares_owned_after":83158.0,"shares_owned_after_display":"83,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-01","filed_date":"2023-12-05","scope":"insider","n_lines":3},{"id":6231354,"accession":"0001764013-22-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-22-000126","line_url":"/filing/0001764013-22-000126#line-1","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":84000.0,"total_display":"84,000.00","total_whole":"84,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider"},{"id":6401303,"accession":"0001593968-22-000362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-22-000362","line_url":"/filing/0001593968-22-000362#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":110.8,"price_display":"110.80","price_state":"stated","total_value":277000.0,"total_display":"277,000.00","total_whole":"277,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-01","filed_date":"2022-02-02","scope":"insider"},{"id":6523522,"accession":"0001593968-22-000017","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-22-000017","line_url":"/filing/0001593968-22-000017#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":130.44,"price_display":"130.44","price_state":"stated","total_value":326100.0,"total_display":"326,100.00","total_whole":"326,100","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-03","scope":"insider"},{"id":4576814,"accession":"0001593968-21-002517","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002517","line_url":"/filing/0001593968-21-002517#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":127.73,"price_display":"127.73","price_state":"stated","total_value":319325.0,"total_display":"319,325.00","total_whole":"319,325","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider"},{"id":5382134,"accession":"0001593968-21-002355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002355","line_url":"/filing/0001593968-21-002355#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":136.67,"price_display":"136.67","price_state":"stated","total_value":341675.0,"total_display":"341,675.00","total_whole":"341,675","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-01","filed_date":"2021-11-03","scope":"insider"},{"id":5010153,"accession":"0001593968-21-002217","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002217","line_url":"/filing/0001593968-21-002217#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":120.72,"price_display":"120.72","price_state":"stated","total_value":301800.0,"total_display":"301,800.00","total_whole":"301,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-01","scope":"insider"},{"id":5418596,"accession":"0001593968-21-002050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-002050","line_url":"/filing/0001593968-21-002050#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":117.82,"price_display":"117.82","price_state":"stated","total_value":294550.0,"total_display":"294,550.00","total_whole":"294,550","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-01","filed_date":"2021-09-01","scope":"insider"},{"id":4114932,"accession":"0001764013-21-000088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764013-21-000088","line_url":"/filing/0001764013-21-000088#line-1","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Immunovant, Inc.","issuer_ticker":"IMVT","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.98,"price_display":"7.98","price_state":"stated","total_value":39900.0,"total_display":"39,900.00","total_whole":"39,900","shares_owned_after":45200.0,"shares_owned_after_display":"45,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-13","filed_date":"2021-08-16","scope":"insider"},{"id":5265674,"accession":"0001593968-21-001919","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001919","line_url":"/filing/0001593968-21-001919#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":114.17,"price_display":"114.17","price_state":"stated","total_value":285425.0,"total_display":"285,425.00","total_whole":"285,425","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-02","scope":"insider"},{"id":5229117,"accession":"0001593968-21-001740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001740","line_url":"/filing/0001593968-21-001740#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":112.66,"price_display":"112.66","price_state":"stated","total_value":281650.0,"total_display":"281,650.00","total_whole":"281,650","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-01","scope":"insider"},{"id":5497832,"accession":"0001593968-21-001490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001490","line_url":"/filing/0001593968-21-001490#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":111.44,"price_display":"111.44","price_state":"stated","total_value":278600.0,"total_display":"278,600.00","total_whole":"278,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-01","scope":"insider"},{"id":4151295,"accession":"0001593968-21-001217","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001593968-21-001217","line_url":"/filing/0001593968-21-001217#line-4","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":110.61,"price_display":"110.61","price_state":"stated","total_value":276525.0,"total_display":"276,525.00","total_whole":"276,525","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-03","scope":"insider"},{"id":4151289,"accession":"0001593968-21-001217","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-001217","line_url":"/filing/0001593968-21-001217#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":120.01,"price_display":"120.01","price_state":"stated","total_value":300025.0,"total_display":"300,025.00","total_whole":"300,025","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-01","filed_date":"2021-05-03","scope":"insider"},{"id":5077548,"accession":"0001593968-21-000765","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-000765","line_url":"/filing/0001593968-21-000765#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":125.43,"price_display":"125.43","price_state":"stated","total_value":313575.0,"total_display":"313,575.00","total_whole":"313,575","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":4391255,"accession":"0001593968-21-000271","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-21-000271","line_url":"/filing/0001593968-21-000271#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":100.0,"price_display":"100.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-01","scope":"insider"},{"id":2157571,"accession":"0001593968-20-002354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-002354","line_url":"/filing/0001593968-20-002354#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5714.0,"shares_display":"5,714","price_per_share":92.64,"price_display":"92.64","price_state":"stated","total_value":529344.96,"total_display":"529,344.96","total_whole":"529,345","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-14","scope":"insider"},{"id":2494743,"accession":"0001636050-20-000105","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001636050-20-000105","line_url":"/filing/0001636050-20-000105#line-1","is_derivative":false,"issuer_cik":"0001636050","issuer_name":"Sio Gene Therapies Inc.","issuer_ticker":"SIOX","issuer_name_source":null,"issuer_url":"/issuer/0001636050","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.3399,"price_display":"2.34","price_state":"stated","total_value":23399.0,"total_display":"23,399.00","total_whole":"23,399","shares_owned_after":33370.0,"shares_owned_after_display":"33,370","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-24","filed_date":"2020-11-25","scope":"insider"},{"id":2081084,"accession":"0001593968-20-002188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-002188","line_url":"/filing/0001593968-20-002188#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":96.84,"price_display":"96.84","price_state":"stated","total_value":484200.0,"total_display":"484,200.00","total_whole":"484,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-12","scope":"insider"},{"id":3314678,"accession":"0001593968-20-002123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-002123","line_url":"/filing/0001593968-20-002123#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-03","scope":"insider"},{"id":2377952,"accession":"0001593968-20-001897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001897","line_url":"/filing/0001593968-20-001897#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-16","filed_date":"2020-09-18","scope":"insider"},{"id":2493447,"accession":"0001593968-20-001751","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001751","line_url":"/filing/0001593968-20-001751#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-14","scope":"insider"},{"id":2377925,"accession":"0001593968-20-001752","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001752","line_url":"/filing/0001593968-20-001752#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-14","scope":"insider"},{"id":2081050,"accession":"0001593968-20-001631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001631","line_url":"/filing/0001593968-20-001631#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":95.43,"price_display":"95.43","price_state":"stated","total_value":477150.0,"total_display":"477,150.00","total_whole":"477,150","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-13","filed_date":"2020-07-13","scope":"insider"},{"id":3010829,"accession":"0001209191-20-042216","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-042216","line_url":"/filing/0001209191-20-042216#line-1","is_derivative":false,"issuer_cik":"0001636050","issuer_name":"Axovant Gene Therapies Ltd.","issuer_ticker":"AXGT","issuer_name_source":null,"issuer_url":"/issuer/0001636050","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.729,"price_display":"2.73","price_state":"stated","total_value":27290.0,"total_display":"27,290.00","total_whole":"27,290","shares_owned_after":23370.0,"shares_owned_after_display":"23,370","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-08","filed_date":"2020-07-10","scope":"insider"},{"id":2873584,"accession":"0001593968-20-001465","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001593968-20-001465","line_url":"/filing/0001593968-20-001465#line-2","is_derivative":false,"issuer_cik":"0001643071","issuer_name":"Karuna Therapeutics, Inc.","issuer_ticker":"KRTX","issuer_name_source":null,"issuer_url":"/issuer/0001643071","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":93.27,"price_display":"93.27","price_state":"stated","total_value":466350.0,"total_display":"466,350.00","total_whole":"466,350","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-12","filed_date":"2020-06-15","scope":"insider"},{"id":2964018,"accession":"0001209191-20-020125","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-020125","line_url":"/filing/0001209191-20-020125#line-1","is_derivative":false,"issuer_cik":"0001636050","issuer_name":"Axovant Gene Therapies Ltd.","issuer_ticker":"AXGT","issuer_name_source":null,"issuer_url":"/issuer/0001636050","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.7844,"price_display":"1.78","price_state":"stated","total_value":17844.0,"total_display":"17,844.00","total_whole":"17,844","shares_owned_after":13370.0,"shares_owned_after_display":"13,370","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":8101024,"accession":"0001209191-19-037522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-037522","line_url":"/filing/0001209191-19-037522#line-1","is_derivative":false,"issuer_cik":"0001636050","issuer_name":"Axovant Gene Therapies Ltd.","issuer_ticker":"AXGT","issuer_name_source":null,"issuer_url":"/issuer/0001636050","owner_cik":"0001643071","owner_name":"Pande Atul","owner_display_name":"Pande Atul","owner_url":"/insider/0001643071","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3370.0,"shares_display":"3,370","price_per_share":5.2212,"price_display":"5.22","price_state":"stated","total_value":17595.444,"total_display":"17,595.44","total_whole":"17,595","shares_owned_after":3370.0,"shares_owned_after_display":"3,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001764013","name":"Immunovant, Inc.","url":"/issuer/0001764013","role":"Director","n_filings":8,"first_seen":"2021-08-16","last_seen":"2026-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001771917","name":"Karuna Therapeutics, Inc.","url":"/issuer/0001771917","role":"Director","n_filings":20,"first_seen":"2020-06-15","last_seen":"2022-02-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001636050","name":"Sio Gene Therapies Inc.","url":"/issuer/0001636050","role":"Director","n_filings":4,"first_seen":"2019-06-17","last_seen":"2020-11-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643071","retrieved_at":"2026-08-22T23:59:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}